Horizon Pharma plc to Participate in the Cowen and Company 38th Annual Health Care Conference

DUBLIN, Ireland, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Horizon Pharma plc HZNP today announced that the company will present at the following conference in March:

Cowen and Company 38th Annual Health Care Conference

  • Date:  March 12, 2018
  • Presentation Time:  4:10 p.m. ET
  • Location:  Boston, Mass.

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.  A replay of the webcast will be available for the event.

About Horizon Pharma plc

Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases.  By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians.  For us, it's personal:  by living up to our own potential, we are helping others live up to theirs.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.

                                                                                                                                      

Contacts:

Investors:                                                                            

Tina Ventura

Senior Vice President,

Investor Relations

investor-relations@horizonpharma.com

Ruth Venning

Executive Director,

Investor Relations

investor-relations@horizonpharma.com

U.S. Media:

Geoff Curtis

Senior Vice President,

Corporate Affairs & Chief Communications Officer

media@horizonpharma.com

Ireland Media:

Ray Gordon

Gordon MRM

ray@gordonmrm.ie

Primary Logo

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!